like most of the suffering shareholders, Wes misjudged managements ability to deliver on their promises such as shareholder value being the key to partnering deals, consolidation to attract US funds just to name a few
Ann: Validation for NNZ-2591 neurodevelopmental disorder pipeline, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.16 |
Change
0.305(2.37%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.636M | 353.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 180 | $13.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.16 | 379 | 7 |
View Market Depth
| Last trade - 12.53pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |